Archive: 28/04/2020
Drug prevents severe cardiac events in children undergoing chemotherapy for AML
The cardioprotective drug dexrazoxane preserved cardiac function in pediatric patients undergoing chemotherapy for acute myeloid leukemia (AML) without compromising overall patient survival and potentially improving it, according ...
Apr 28, 2020